Trials / Completed
CompletedNCT00414778
Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
A Single-center, Open-label, Single and Multiple Oral Dose Study to Assess Safety and Pharmacokinetics of LHT344 in Chinese Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate safety and pharmacokinetics of a single and multiple dose of LHT344 in 12 Chinese healthy subjects. This study is not recruiting subjects in the United States.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LHT344 |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2006-10-01
- First posted
- 2006-12-22
- Last updated
- 2011-01-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00414778. Inclusion in this directory is not an endorsement.